APA (7th ed.) Citation

Folschweiller, N., Behre, U., Dionne, M., Durando, P., Esposito, S., Ferguson, L., . . . Struyf, F. (2019). Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine. Journal of Infectious Diseases, 219(11), 1799. https://doi.org/10.1093/infdis/jiy743

Chicago Style (17th ed.) Citation

Folschweiller, Nicolas, et al. "Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine." Journal of Infectious Diseases 219, no. 11 (2019): 1799. https://doi.org/10.1093/infdis/jiy743.

MLA (9th ed.) Citation

Folschweiller, Nicolas, et al. "Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine." Journal of Infectious Diseases, vol. 219, no. 11, 2019, p. 1799, https://doi.org/10.1093/infdis/jiy743.